Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis

Clinical Nephrology

Volumn 75, Issue 5, 2011, Pages 397-402

  Lee, C T ^a   Tsai, Y C ^a   Su, C Y ^a   Ng, H Y ^a   Hsu, C Y ^b   Ko, S F ^a   Chen, T C ^a   Kuo, C C ^a   Yang, C C ^a   Chiou, T Y ^a   Lee, W C ^a   Yang, Y K ^a   Lam, K K ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Peritoneal dialysis; Pro inflammatory cytokine; Residual kidney function; Vascular calcification

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PELVIS RADIOGRAPHY; PERITONEAL DIALYSIS; RISK FACTOR; THORAX RADIOGRAPHY; AGED; BLOOD; CALCINOSIS; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASE;

ADULT; AGED; CALCINOSIS; FEMALE; HUMANS; INTERLEUKIN-10; KIDNEY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RADIOGRAPHY, THORACIC; RISK FACTORS; VASCULAR DISEASES;

EID: 79958731085     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75397     Document Type: Article

References (31)

1. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52: 1527-1539.
2. London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens. 2005; 14: 525-531.
3. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997; 51: 1678-1695.
4. GoodmanWG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342: 1478-1483.
5. Lodon GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18: 1731-1740.
6. Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves M, Negrão AP. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant. 2009; 24: 997-1002.
7. Johnson RC, Leopold JA, Loscalzo J.Vascular calcification: pathobiologicalmechanisms and clinical implications. Circ Res. 2006; 99: 1044-1059.
8. Tsirpanlis G. Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease. Blood Purif. 2007; 25: 179-182.
9. Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006; 17: 274-280.
10. Chung SH, Heimbürger O, Lindholm B, Stenvinkel P. Chronic inflammation in PD patients. Contrib Nephrol. 2003; 140: 104-111.
11. Bellasi A, Raggi P. Techniques and technologies to assess vascular calcification. Semin Dial. 2007; 20: 129-133.
12. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP. Asimple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004; 19: 1480-1488.
13. Shigematsu T, Kono T, Satoh K, Yokoyama K, Yoshida T, Hosoya T, Shirai K. Phosphate overload accelerates vascular calcium deposition in endstage renal disease patients. Nephrol Dial Transplant. 2003; 18: 86-89.
14. Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y. Presence of Abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007; 49: 417-425.
15. Honkanen E, Kauppila L, Wikström B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B; CORD study group. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant. 2008; 23: 4009-4015.
16. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis. 2003; 42: 355-361.
17. Stompór T, Pasowicz M, Sulowicz W, Dembinska-Kiec A, Janda K, Wójcik K, TraczW, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003; 41: 203-211.
18. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004; 19 (Suppl): 59-66.
19. Dellegrottaglie S, Sanx J, Raiagopalan S. Molecular determinants of vascular calcification: a bench to bedside view. Curr Mol Med. 2006; 6: 515-524.
20. Lee CT, Tasi YC, Ng HY, Su Y, Lee WC, Lee LC, Chiou TT, Liao SC, Hsu KT. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients-a cross sectional study. J Ren Nutr. 2009; 19: 220-227.
21. Stenvinkel P, Alvestrand A. Inflammation in endstage renal disease: sources, consequences, and therapy. Semi Dial. 2002; 15: 329-337.
22. Girndt M, Köhler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplant. 2003; 18: 1976-1979.
23. Lu Y, Hylander B, Brauner A. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1996; 16: 607-612.
24. Porazko T, Kuzniar J, Kusztal M, Kuzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M. IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant. 2009; 24: 589-596.
25. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol. 2007; 27: 98-114.
26. ChiangCK, HsuSP, PaiMF, PengYS, HoTI, LiuSH, HungKY, Tsai TJ. Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol Dial Transplant. 2004; 19: 2810-2815.
27. Yang JY, Huang JW, Chiang CK, Pan CC, Wu KD, Tsai TJ, Chen WY. Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol Dial Transplant. 2007; 22: 3606-3609.
28. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006; 69: 1726-1732.
29. Marron B, Remon C, Perez-Fontan M, Quiros P, Ortiz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int. 2008; 73: 42-S1.
30. Wang AY. Vascular and other tissue calcification in peritoneal dialysis patients. Perit Dial Int. 2009; 29 (Suppl): 9-14.
31. Shanahan CM. Vascular calcification. Curr Opin Nephrol Hypertens. 2005; 14: 361-367.